Romiplostim before splenectomy in a patient with aggressive non-Hodgkin lymphoma and poor response to platelet transfusions.
Haematology Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, 50134, Florence, Italy.
S
S
Baldini
V
V
Carrai
B
B
Puccini
L
L
Rigacci
R
R
Alterini
A
A
Bosi
D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000097:blood / Q000628:therapy*; D017713:Platelet Transfusion; D011241:Prednisone / Q000008:administration & dosage; D011961:Receptors, Fc / Q000008:administration & dosage*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D000069283:Rituximab; D013156:Splenectomy; D013926:Thrombopoietin / Q000008:administration & dosage*; D014750:Vincristine / Q000008:administration & dosage
D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D013926:Thrombopoietin; C488777:romiplostim; D011241:Prednisone